PA
RMD icon

Procyon Advisors’s ResMed RMD Stock Holding History

Procyon Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Sell
2,228
-110
-5% -$22.8K 0.02% 384
2026
Q1 		$525K Buy
2,338
+904
+63% +$225K 0.03% 342
2025
Q4 		$345K Sell
1,434
-290
-17% -$74.2K 0.02% 404
2025
Q3 		$472K Buy
1,724
+715
+71% +$195K 0.03% 323
2025
Q2 		$260K Buy
1,009
+84
+9% +$20K 0.02% 398
2025
Q1 		$207K Buy
+925
New +$216K 0.01% 562
2020
Q3 		– Sell
-3
Closed -$1K – 863
2020
Q2 		$1K Hold
3
– – ﹤0.01% 1018
2020
Q1 		$0 Hold
3
– – ﹤0.01% 1132
2019
Q4 		$0 Buy
+3
New +$432 ﹤0.01% 1059

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Procyon Advisors's RMD Position: Q2 2026 in Review

Procyon Advisors reduced its ResMed (RMD) stake by 4.7% in Q2 2026, selling an estimated $22.8K and leaving 2,228 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #384.

Procyon Advisors first reported a position in RMD in Q4 2019 and has held it in 9 quarters since. The position peaked at $525K in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Procyon Advisors held 2,228 shares of ResMed worth $434K as of Q2 2026.
  • Procyon Advisors sold 110 ResMed shares in Q2 2026, an estimated $22.8K.
  • ResMed made up 0.02% of Procyon Advisors's portfolio in Q2 2026, its #384 holding.
  • Procyon Advisors first reported a position in ResMed in Q4 2019 and has held it in 9 quarters since.
  • Procyon Advisors's ResMed position peaked at $525K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.